Myriad Genetics, Inc. (MYGN)

4.705 +0.16 (+3.63%) USD  |  NASDAQ  |  Jun 10, 10:29
More

Myriad Genetics EBITDA Margin (TTM)

EBITDA Margin (TTM) Chart

View EBITDA Margin (TTM) for MYGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin (TTM) Range, Past 5 Years

View EBITDA Margin (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin (TTM) Benchmarks

View EBITDA Margin (TTM) Benchmarks
Start Trial
Natera, Inc. Upgrade
BioRestorative Therapies, Inc. Upgrade
CareDx, Inc. Upgrade
Exagen, Inc. Upgrade
Sera Prognostics, Inc. Upgrade